Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Rochester › NPI 1184725525
Physician

U of R Neurology Department

U of R Neurology Department was paid $61.71M by Medicaid between Jan 2018 and Dec 2024, across 462 billing codes. Its largest line is 90791, psychiatric diagnostic evaluation — 13% of everything it billed.

33Billing provider infoU OF R NEUROLOGY DEPARTMENT
ROCHESTER, NY 14642
33aNPI1184725525assigned 09/26/2006
33bProvider typeNeurology Physician
28Total paid$61.71M
24GClaims1,105,121
24DCodes billed462
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Neurology Physician providers in New York

Rank by total paid#1 of 623
Median peer was paid$9K
This provider vs. median6,570×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official HETTERICH, JILL controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018370$42K
2019178,493$8.55M
2020161,837$8.39M
2021203,720$11.58M
2022205,663$12.33M
2023222,586$12.64M
2024incomplete132,452$8.17M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
90791 Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation 13% 5,832 4,682 $7.80M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 6.0% 21,765 20,262 $3.68M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 4.5% 14,935 14,332 $2.80M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 4.3% 12,224 11,459 $2.67M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 4.3% 13,946 12,929 $2.64M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3.0% 14,816 7,665 $1.82M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.8% 20,332 19,418 $1.71M
99215 Doctor's office visit, returning patient (complex)Prolong outpt/office vis 2.7% 9,308 8,414 $1.66M
96415 2.4% 1,726 1,481 $1.48M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 2.0% 5,735 3,925 $1.24M
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.0% 5,543 5,245 $1.23M
S9485 Crisis intervention mental health services, per diem 1.8% 576 527 $1.09M
450 more codes
H0020 Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) 1.7% 37,608 $1.07M
96361 Intravenous infusion, hydration; each additional hour 1.6% 3,013 $1.01M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.6% 4,242 $1.00M
Q5103 Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg 1.6% 691 $963K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1.4% 1,114 $887K
90834 Psychotherapy session, about 45 minutes 1.4% 6,624 $871K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.4% 2,523 $850K
70450 Computed tomography, head or brain; without contrast material 1.3% 2,223 $813K
80053 Comprehensive metabolic panel 1.3% 38,853 $799K
99285 Emergency room visit (most serious) 1.2% 3,912 $732K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 1.1% 1,725 $666K
G0378 Hospital observation service, per hour 1.1% 3,756 $654K
87631 1.0% 4,989 $623K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 2,117 $588K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 301 $564K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 2,863 $544K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 13,399 $508K
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study <1% 1,135 $478K
D2930 Prefabricated stainless steel crown - primary tooth <1% 441 $461K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 455 $456K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 13,334 $454K
97161 <1% 2,694 $451K
80048 Basic metabolic panel (calcium, ionized) <1% 17,328 $437K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 1,837 $401K
90832 Psychotherapy session, about 30 minutes <1% 3,952 $399K
H0040 Assertive community treatment program, per diem <1% 230 $397K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 7,966 $376K
D9223 Deep sedation/general anesthesia - each subsequent 15 minute increment <1% 573 $374K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,349 $372K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 8,097 $357K
90837 Psychotherapy session, about an hour <1% 2,595 $332K
76770 <1% 1,618 $332K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 12,899 $319K
59025 Fetal non-stress test <1% 1,041 $301K
92567 <1% 2,340 $252K
83036 Hemoglobin; glycosylated (A1C) <1% 17,665 $247K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 892 $244K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 7,808 $243K
86850 <1% 5,869 $239K
84443 Thyroid stimulating hormone (TSH) <1% 19,350 $229K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 363 $225K
95812 <1% 518 $224K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 10,028 $221K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 1,084 $208K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 4,960 $207K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,973 $194K
97162 <1% 936 $190K
87536 <1% 1,392 $190K
D9222 <1% 556 $189K
92134 <1% 1,433 $189K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 7,521 $186K
86901 <1% 6,048 $164K
80061 Lipid panel <1% 16,806 $161K
80051 <1% 4,364 $156K
92557 <1% 1,364 $156K
41899 Unlisted procedure, dentoalveolar structures <1% 86 $152K
99205 Prolong outpt/office vis <1% 774 $149K
80076 <1% 7,808 $145K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 2,293 $140K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 48,096 $140K
86780 <1% 7,627 $135K
36415 Collection of venous blood by venipuncture <1% 41,941 $131K
93320 <1% 1,607 $124K
86900 <1% 6,036 $121K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 6,148 $120K
94010 <1% 676 $112K
84439 <1% 9,676 $111K
94060 <1% 332 $111K
93325 <1% 1,938 $109K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,641 $106K
86803 <1% 7,802 $105K
82728 <1% 6,601 $103K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 5,610 $102K
87086 Culture, bacterial; quantitative colony count, urine <1% 11,532 $101K
83880 <1% 2,037 $99K
99204 Doctor's office visit, new patient (more involved) <1% 475 $96K
92133 <1% 569 $94K
97803 <1% 1,677 $94K
86480 <1% 1,124 $88K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 105 $87K
H0035 Mental health partial hospitalization, treatment, less than 24 hours <1% 519 $84K
87522 Neg quan hep c or qual rna <1% 1,253 $84K
82607 <1% 5,044 $83K
92579 <1% 752 $81K
84403 <1% 2,504 $81K
93975 <1% 249 $80K
87340 <1% 5,524 $76K
86360 <1% 1,494 $75K
83970 <1% 1,169 $74K
87480 <1% 4,517 $73K
Q9956 Injection, octafluoropropane microspheres, per ml <1% 1,438 $73K
87510 <1% 4,517 $73K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 9,446 $72K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 38 $71K
95886 <1% 455 $69K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 1,698 $67K
93017 <1% 350 $66K
82670 <1% 1,547 $65K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 70 $64K
88342 <1% 1,154 $62K
90847 Family psychotherapy with the patient present, 50 minutes <1% 305 $61K
87660 <1% 4,656 $61K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 1,574 $57K
83655 <1% 2,851 $56K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 131 $54K
86359 <1% 1,510 $53K
87081 <1% 8,903 $52K
97010 <1% 1,987 $52K
76882 <1% 369 $51K
85610 <1% 8,648 $50K
86706 <1% 3,811 $49K
85027 <1% 14,456 $46K
88185 <1% 419 $45K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 143 $45K
86704 <1% 3,566 $45K
J1459 Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg <1% 13 $43K
95951 <1% 164 $41K
86762 <1% 1,859 $39K
J7120 Ringers lactate infusion, up to 1000 cc <1% 11,946 $39K
83540 <1% 6,233 $39K
H2011 Crisis intervention service, per 15 minutes <1% 511 $38K
88341 <1% 670 $37K
82570 <1% 5,242 $36K
84702 <1% 2,628 $35K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,894 $35K
J1745 Injection, infliximab, excludes biosimilar, 10 mg <1% 12 $35K
D1120 Dental cleaning, child <1% 444 $33K
70551 Magnetic resonance imaging, brain; without contrast material <1% 91 $33K
99232 Hospital visit by a doctor, follow-up day <1% 522 $32K
97165 <1% 223 $32K
71275 Computed tomographic angiography, chest, with contrast material <1% 75 $31K
83735 <1% 8,455 $30K
87186 <1% 3,536 $30K
86708 <1% 2,204 $30K
86140 <1% 7,165 $29K
84146 <1% 989 $29K
76830 Ultrasound, transvaginal <1% 734 $29K
J2704 Injection, propofol, 10 mg <1% 9,487 $29K
82746 <1% 1,811 $28K
95720 <1% 209 $28K
97802 <1% 591 $28K
D3220 Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction <1% 98 $27K
93971 <1% 404 $27K
A9576 Injection, gadoteridol, (prohance multipack), per ml <1% 1,240 $27K
82784 <1% 2,258 $26K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 360 $26K
83001 <1% 970 $26K
81001 <1% 8,217 $26K
83550 <1% 3,969 $25K
82043 <1% 3,355 $25K
A9573 Injection, gadopiclenol, 1 ml <1% 505 $24K
97164 <1% 224 $23K
71046 Radiologic examination, chest; 2 views <1% 6,178 $23K
80069 <1% 1,516 $23K
84466 <1% 1,699 $23K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 1,485 $23K
12001 <1% 39 $22K
J1170 Injection, hydromorphone, up to 4 mg <1% 3,390 $21K
87070 <1% 2,591 $21K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 102 $20K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 7,679 $20K
92083 <1% 167 $20K
80197 <1% 1,978 $20K
96367 <1% 160 $20K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 54 $20K
84402 <1% 833 $19K
A9585 Injection, gadobutrol, 0.1 ml <1% 626 $18K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 1,339 $17K
93976 <1% 105 $17K
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 816 $17K
76000 <1% 149 $17K
90715 <1% 529 $16K
92556 <1% 246 $16K
88112 <1% 260 $16K
92552 <1% 107 $16K
86355 <1% 375 $16K
59841 <1% 14 $15K
74183 <1% 32 $15K
84100 <1% 5,200 $15K
J2469 Injection, palonosetron hcl, 25 mcg <1% 824 $14K
83002 <1% 520 $13K
85652 <1% 6,283 $13K
86038 <1% 1,722 $12K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 76 $12K
70486 <1% 106 $12K
82565 <1% 8,266 $12K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 180 $12K
82805 <1% 551 $12K
73610 <1% 1,814 $12K
83690 <1% 8,703 $12K
99223 Prolong inpt eval add15 m <1% 72 $11K
83615 <1% 3,654 $11K
73630 <1% 1,786 $11K
85730 <1% 2,404 $11K
88304 <1% 278 $11K
84460 <1% 2,932 $11K
J0690 Injection, cefazolin sodium, 500 mg <1% 3,827 $10K
78815 Positron emission tomography (PET) for limited area imaging <1% 12 $10K
71250 <1% 97 $10K
82105 <1% 1,165 $10K
86357 <1% 364 $10K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 966 $10K
0071A <1% 161 $10K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 9,027 $10K
G0124 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician <1% 697 $9K
84156 <1% 2,087 $9K
90853 Group psychotherapy (other than of a multiple-family group) <1% 186 $9K
0001A <1% 243 $9K
12002 <1% 14 $9K
86787 <1% 933 $9K
88307 <1% 90 $9K
99222 Initial hospital care, per day, moderate complexity <1% 85 $9K
92250 <1% 126 $9K
82248 <1% 2,984 $9K
81025 <1% 1,898 $8K
73030 <1% 1,094 $8K
76536 <1% 287 $8K
86765 <1% 428 $8K
99233 Hospital visit by a doctor, follow-up day (complex) <1% 112 $8K
87102 <1% 959 $8K
84450 <1% 1,328 $8K
82950 <1% 995 $8K
0002A <1% 126 $8K
70498 <1% 56 $8K
82150 <1% 8,229 $8K
86481 <1% 106 $7K
87529 <1% 88 $7K
86618 <1% 339 $7K
0012A <1% 136 $7K
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,608 $7K
85380 <1% 390 $7K
86364 <1% 710 $7K
0124A <1% 112 $7K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 8,727 $6K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 8,162 $6K
82550 <1% 1,621 $6K
88184 <1% 253 $6K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 107 $6K
D7140 Extraction, erupted tooth or exposed root <1% 12 $6K
85007 <1% 4,909 $6K
87205 <1% 1,968 $6K
95885 <1% 55 $6K
99203 Doctor's office visit, new patient (routine) <1% 27 $6K
90686 <1% 438 $6K
85014 <1% 2,037 $6K
74018 <1% 1,400 $6K
72125 Computed tomography, cervical spine; without contrast material <1% 91 $6K
73130 <1% 1,300 $6K
82977 <1% 912 $6K
72082 <1% 329 $5K
93296 <1% 34 $5K
86376 <1% 254 $5K
88321 <1% 105 $5K
72100 <1% 720 $5K
99231 Subsequent hospital care, per day, straightforward or low complexity <1% 159 $5K
J8540 Dexamethasone, oral, 0.25 mg <1% 1,363 $5K
86430 <1% 757 $5K
82247 <1% 2,689 $5K
73562 <1% 812 $5K
84550 <1% 1,084 $5K
0011A <1% 155 $5K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 12,256 $5K
87497 <1% 104 $5K
81003 <1% 3,674 $5K
J1756 Injection, iron sucrose, 1 mg <1% 121 $5K
74230 <1% 12 $5K
72156 <1% 12 $4K
84480 <1% 653 $4K
73560 <1% 696 $4K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 574 $4K
D1208 Topical application of fluoride, excluding varnish <1% 64 $4K
86923 <1% 102 $4K
82040 <1% 2,481 $4K
J7060 5% dextrose/water (500 ml = 1 unit) <1% 1,595 $4K
82533 <1% 222 $4K
93299 <1% 24 $4K
83020 <1% 260 $4K
99221 <1% 40 $4K
0072A <1% 63 $4K
82947 <1% 7,439 $4K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 8,350 $4K
86735 <1% 326 $4K
74178 <1% 29 $3K
0004A <1% 58 $3K
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose <1% 80 $3K
93225 <1% 13 $3K
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous <1% 281 $3K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,906 $3K
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge <1% 304 $3K
88189 <1% 68 $3K
88142 <1% 114 $3K
73110 <1% 562 $3K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 63 $3K
82785 <1% 193 $3K
73502 <1% 449 $3K
86160 <1% 197 $3K
84075 <1% 1,863 $3K
84165 <1% 382 $3K
86800 <1% 132 $3K
99443 <1% 24 $2K
82310 <1% 2,257 $2K
87338 <1% 205 $2K
73590 <1% 463 $2K
72170 <1% 278 $2K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 12 $2K
96402 <1% 28 $2K
J0780 Injection, prochlorperazine, up to 10 mg <1% 535 $2K
95909 <1% 27 $2K
84155 <1% 2,350 $2K
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 342 $2K
84520 <1% 6,718 $2K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,218 $2K
84481 <1% 158 $2K
J1644 Injection, heparin sodium, per 1000 units <1% 1,281 $2K
97166 <1% 12 $2K
92611 <1% 12 $2K
94729 <1% 65 $2K
87040 <1% 1,822 $2K
J7042 5% dextrose/normal saline (500 ml = 1 unit) <1% 857 $2K
31575 <1% 13 $2K
J2550 Injection, promethazine hcl, up to 50 mg <1% 737 $2K
86696 <1% 121 $2K
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg <1% 166 $2K
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg <1% 96 $2K
85045 <1% 935 $2K
84295 <1% 2,599 $2K
J1650 Injection, enoxaparin sodium, 10 mg <1% 536 $2K
71045 Radiologic examination, chest; single view <1% 1,505 $2K
J1630 Injection, haloperidol, up to 5 mg <1% 1,327 $2K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 43 $2K
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 198 $2K
88313 <1% 168 $2K
D1351 Sealant - per tooth <1% 12 $2K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 26 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 768 $2K
Q9950 Injection, sulfur hexafluoride lipid microspheres, per ml <1% 25 $1K
86235 <1% 52 $1K
86077 <1% 28 $1K
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 820 $1K
73140 <1% 290 $1K
93226 <1% 13 $1K
87641 <1% 49 $1K
84703 <1% 2,811 $1K
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation <1% 13 $1K
82435 <1% 2,291 $1K
82374 <1% 2,089 $1K
J3475 Injection, magnesium sulfate, per 500 mg <1% 313 $1K
86008 <1% 40 $1K
93922 <1% 39 $1K
85060 <1% 87 $1K
88319 <1% 22 $1K
83993 <1% 67 $1K
86665 <1% 49 $1K
73090 <1% 310 $1K
87088 <1% 99 $1K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 3,567 $1K
87158 <1% 1,791 $1K
73564 <1% 66 $1K
0031A <1% 17 $1K
84132 <1% 864 $997.35
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 637 $991.22
85384 <1% 268 $935.29
76801 <1% 12 $928.05
87206 <1% 168 $921.77
73070 <1% 141 $866.76
73100 <1% 135 $851.19
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 348 $840.44
0054A <1% 14 $840.00
85097 <1% 12 $815.20
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 367 $805.31
88312 <1% 17 $788.37
86592 <1% 178 $751.08
83605 <1% 1,453 $705.59
73080 <1% 115 $704.62
S9484 Crisis intervention mental health services, per hour <1% 17 $655.41
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 108 $627.59
86769 <1% 12 $568.80
86225 <1% 77 $568.71
84153 <1% 27 $551.80
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 3,064 $539.28
G0008 Administration of influenza virus vaccine <1% 32 $521.04
84134 <1% 64 $514.51
85018 <1% 219 $489.50
82378 <1% 44 $485.83
J1030 Injection, methylprednisolone acetate, 40 mg <1% 51 $471.08
87535 <1% 12 $440.62
V5266 Battery for use in hearing device <1% 39 $435.60
95911 <1% 12 $435.42
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 212 $434.49
86709 <1% 28 $427.50
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 1,577 $418.19
73552 <1% 87 $417.49
87184 <1% 26 $401.42
84484 <1% 3,827 $401.16
97035 <1% 18 $352.44
83521 <1% 42 $320.70
82330 <1% 224 $314.03
86304 <1% 12 $312.20
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 1,074 $310.90
87324 <1% 44 $282.00
82390 <1% 25 $255.15
83525 <1% 13 $205.80
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 12 $198.24
86308 <1% 50 $196.53
Q0164 Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 367 $196.22
87449 <1% 31 $195.00
86301 <1% 13 $187.32
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 2,649 $176.70
87015 <1% 27 $170.54
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,594 $167.27
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 909 $151.77
87116 <1% 13 $141.93
72040 <1% 15 $136.40
J1815 Injection, insulin, per 5 units <1% 92 $133.71
J1596 Injection, glycopyrrolate, 0.1 mg <1% 122 $125.88
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 13 $117.81
87075 <1% 28 $113.68
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 4,756 $90.34
83721 <1% 220 $80.70
72070 <1% 13 $68.20
J2060 Injection, lorazepam, 2 mg <1% 70 $55.68
Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml <1% 14 $55.10
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram <1% 134 $51.97
96375 Therapeutic injection; each additional sequential IV push <1% 5,702 $50.22
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 91 $48.40
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg <1% 33 $38.64
81002 <1% 1,383 $36.20
80143 <1% 989 $25.44
85390 <1% 399 $20.15
J2470 Injection, pantoprazole sodium, 40 mg <1% 12 $15.60
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 16 $14.98
80179 <1% 975 $12.72
88300 <1% 474 $8.84
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,023 $7.50
99153 Mod sedat endo service >5yrs 0% 1,475 $0.00
C1769 Guide wire 0% 1,046 $0.00
96376 0% 1,367 $0.00
82077 0% 534 $0.00
95012 0% 91 $0.00
96127 0% 13 $0.00
99152 0% 2,320 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 567 $0.00
G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) 0% 115 $0.00
96417 0% 87 $0.00
85347 0% 38 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 0% 263 $0.00
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 0% 99 $0.00
C1729 Catheter, drainage 0% 13 $0.00
T1040 Medicaid certified community behavioral health clinic services, per diem 0% 26 $0.00
95800 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHETTERICH, JILL (SENIOR DIRECTOR OF FINANCE URMFG)
Same official

Other billing entities under HETTERICH, JILL

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.